3PE6
Crystal Structure of a soluble form of human MGLL in complex with an inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 17-ID |
Synchrotron site | APS |
Beamline | 17-ID |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-12-03 |
Detector | ADSC QUANTUM 210 |
Wavelength(s) | 1.0 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 93.947, 128.145, 60.602 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 30.420 - 1.350 |
R-factor | 0.1148 |
Rwork | 0.114 |
R-free | 0.14660 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1a8q |
RMSD bond length | 0.014 |
RMSD bond angle | 1.435 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((phenix.refine)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.350 |
High resolution limit [Å] | 1.300 | 1.300 |
Rmerge | 0.062 | 0.319 |
Number of reflections | 79919 | |
<I/σ(I)> | 34.2 | 1.76 |
Completeness [%] | 89.2 | 53.3 |
Redundancy | 2.2 | 1.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6 | 295 | PEGMME5000 MES glucopyranoside, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K |